Sunny Chapel, based in Ann Arbor, MI, US, is currently a President and CEO at A2-Ai, bringing experience from previous roles at TBD, Amador Bioscience and A2PG. Sunny Chapel holds a Doctor of Philosophy - PhD in Pharmacokinetics @ University of Iowa. With a robust skill set that includes Capital Markets, Valuation, Feasibility Studies, Investments, Appraisals and more, Sunny Chapel contributes valuable insights to the industry. Sunny Chapel has 2 emails on RocketReach.